These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12547578)
1. Sildenafil for lung fibrosis and pulmonary hypertension. Kleinsasser A; Loeckinger A Lancet; 2003 Jan; 361(9353):262-3; author reply 263. PubMed ID: 12547578 [No Abstract] [Full Text] [Related]
2. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470 [TBL] [Abstract][Full Text] [Related]
3. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension. Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627 [TBL] [Abstract][Full Text] [Related]
4. Sildenafil for pulmonary arterial hypertension complicating respiratory disease. Aggarwal AN Indian J Chest Dis Allied Sci; 2008; 50(4):317-9. PubMed ID: 19035049 [No Abstract] [Full Text] [Related]
5. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Gordeuk VR Haematologica; 2005 Apr; 90(4):433-4. PubMed ID: 15820926 [No Abstract] [Full Text] [Related]
6. Should we administer sildenafil to patients with obstructive pulmonary disease and pulmonary hypertension? No. Namendys-Silva SA; Hernández-Garay M Am J Respir Crit Care Med; 2010 Nov; 182(9):1206; author reply 1206-7. PubMed ID: 21041564 [No Abstract] [Full Text] [Related]
7. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease. Montgomery GS; Sagel SD; Taylor AL; Abman SH Pediatr Pulmonol; 2006 Apr; 41(4):383-5. PubMed ID: 16479610 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684 [TBL] [Abstract][Full Text] [Related]
9. [Sildenafil in pulmonary hypertension]. Ewert R; Höper M; Halank M; Winkler J; Wensel R; Opitz C Pneumologie; 2003 May; 57(5):291; author reply 291-2; discussion 292. PubMed ID: 12825577 [No Abstract] [Full Text] [Related]
10. Sildenafil in pulmonary arterial hypertension. Confalonieri M; Antonaglia V; Lucangelo U; Gullo A Am J Respir Crit Care Med; 2004 Jun; 169(11):1256; author reply 1256-7. PubMed ID: 15161616 [No Abstract] [Full Text] [Related]
11. [The clinical application of sildenafil in porto pulmonary hypertension]. Shen YC; Wen FQ; Yi Q Zhonghua Jie He He Hu Xi Za Zhi; 2011 Sep; 34(9):691-3. PubMed ID: 22177497 [No Abstract] [Full Text] [Related]
12. [New indications for sildenafil in sight. Potency drug is potent in pulmonary hypertension]. MMW Fortschr Med; 2004 Apr; 146(18):8. PubMed ID: 15366459 [No Abstract] [Full Text] [Related]
18. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence. Raja SG; Danton MD; MacArthur KJ; Pollock JC J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298 [No Abstract] [Full Text] [Related]
19. Pulmonary hypertension in patients with hemoglobinopathies: could a mechanism for dysfunction provide an avenue for novel therapeutics? Lin EE; Gladwin MT; Machado RF Haematologica; 2005 Apr; 90(4):441-4. PubMed ID: 15820937 [No Abstract] [Full Text] [Related]
20. Potentiating the pulmonary vasodilatory effects produced by sildenafil. Dias-Junior CA Respir Med; 2007 May; 101(5):1041; author reply 1042. PubMed ID: 17321734 [No Abstract] [Full Text] [Related] [Next] [New Search]